Fahd Riaz

M&A Transactions

• A large industrial company in its roll up various automotive glass companies
• A large Japanese multinational in its sale and assignment of rights to develop and market certain products in all countries excluding Mexico
• A privately held company in its sale of all of its assets for an upfront and contingent payments totaling more than US$500 million
• A multinational company in its sale of its U.S. Subsidiary
• A multinational company in its acquisition of chemical companies in the United States
• A company in its sale to private equity for over US$500 million
• Sale of carbon recapture company to a multinational company
• Indian-based company in its acquisition of an energy facility in the United States  

Partnering (includes Licensing, Collaboration, Co-Development, and Commercialization)

• U.S. publicly traded company in a multinational license agreement with a Chinese company with a value of over US$1 billion in milestone and royalty payments
• Ivy League university in its Research and Development, Collaboration, License and Option Agreement with a multinational company with a value of US$2 billion
• Japanese pharmaceutical company in a license agreement with a German multinational company
• U.S. pharmaceutical company in its License and Asset Purchase Agreement with a Swiss multinational
• U.S. company in its licensing transaction with a Canadian company to commercialize its products in Canada
• Japanese company in its US$320 million collaboration and development with U.S. multinational company
• Multinational company in its up to US$440 million Collaboration Agreement with a competitor for the development and commercialization of three products
• U.S. agriculture company in its development and commercialization of certain of its products in Europe by a French company providing EU€41million in upfront and milestone payments
• U.S. publicly traded company in its royalty monetization deals with another U.S. publicly traded company

General Corporate

• U.S. publicly traded company in relation to its various research, development and manufacturing agreements
• Global pharmaceutical corporation in connection with numerous clinical study agreements
• U.S. pharmaceutical corporation regarding high-volume clinical study agreements and drafting standard clinical trial documentation
• U.S. publicly traded company in its development of its multinational manufacturing supply chain, including negotiation of its manufacturing and supply agreements with Italian, Japanese, and U.S.-based manufacturing companies

• U.S. publicly traded company in relation to its various research, development and manufacturing agreements
• Ivy League university and various national and global companies in drafting and development of their corporate and commercial form agreements
• Various companies in their corporate development process from formation through public offering and capital markets transactions